Sanofi Consumer Healthcare India Peer Comparison
NSE: SANOFICONR | BSE: 544250
₹3,494.50
As on 19-Nov-2026IST
Market cap
₹8,036 Cr
Revenue (TTM)
₹979 Cr
P/E Ratio
28.7
P/B Ratio
18.9
Div. Yield
2.1 %
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
8,036 | 13,558 | 38,019 | 15,552 | 1,859 |
Revenue (₹ Cr) |
979 | 3,392 | 2,371 | 4,131 | 2,756 |
Net Profit (₹ Cr) |
279.70 | 565.65 | 376.21 | 411.10 | -115.84 |
Net Margin (%) |
27.97 | 16.21 | 15.66 | 9.78 | -4.14 |
RoE (%) |
76.43 | 17.62 | 14.78 | 13.13 | -1.70 |
Price to Earnings |
28.73 | 24.22 | 101.06 | 37.83 | -- |
Price-To-Book |
18.93 | 4.07 | 14.14 | 4.63 | 0.28 |
Income Statement (₹ Cr)
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Operating Revenue
|
979.00 | 3,391.51 | 2,371.47 | 4,130.90 | 2,756.21 |
|
Total Income
|
999.90 | 3,490.38 | 2,402.88 | 4,205.10 | 2,801.01 |
|
Total Expenditure
|
609.40 | 2,608.02 | 1,672.68 | 3,447.90 | 2,374.11 |
|
EBITDA
|
369.60 | 783.49 | 698.79 | 683.00 | 382.10 |
|
Depreciation
|
13.00 | 105.59 | 183.45 | 171.90 | 354.31 |
|
EBIT
|
356.60 | 677.90 | 515.34 | 511.10 | 27.79 |
|
Interest
|
1.70 | 26.08 | 36.10 | 25.10 | 166.28 |
|
Other Income
|
20.90 | 98.87 | 31.41 | 74.20 | 44.80 |
|
Exceptional Items
|
0.00 | 0.00 | -8.00 | -20.30 | -2.84 |
|
Profit before Tax
|
375.80 | 750.70 | 502.65 | 539.90 | -96.53 |
|
Provision for Tax
|
96.10 | 185.04 | 126.43 | 128.80 | 19.31 |
|
Profit after Tax
|
279.70 | 565.65 | 376.21 | 411.10 | -115.84 |
Liabilities (₹ Cr)
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
347.90 | 3,332.35 | 2,688.06 | 3,358.40 | 6,671.07 |
|
Minority Interest
|
0.00 | -5.84 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
31.40 | 392.00 | 329.47 | 217.10 | 2,403.97 |
|
Current Liabilities
|
327.10 | 600.33 | 1,184.75 | 1,117.80 | 2,721.06 |
|
Total Liabilities
|
750.80 | 3,239.63 | 3,209.12 | 3,325.90 | 9,986.90 |
Assets (₹ Cr)
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
22.50 | 911.53 | 2,334.27 | 1,758.50 | 8,353.22 |
|
Current Assets
|
663.40 | 3,012.28 | 1,440.53 | 2,757.40 | 3,013.81 |
|
Total Assets
|
750.80 | 3,239.63 | 3,209.12 | 3,325.90 | 9,986.90 |
|
Total Debt*
|
0.00 | 23.09 | 128.64 | 0.00 | 2,083.91 |
|
Net Current Assets
|
336.30 | 2,411.96 | 255.78 | 1,639.60 | 292.75 |
|
Contingent Liabilities
|
1.50 | -- | 58.11 | -- | 423.42 |
Cashflow (₹ Cr)
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
174.80 | 206.66 | 314.05 | 441.90 | 371.28 |
|
Cash Flow from Investing Activities
|
7.60 | -49.01 | -536.67 | -682.70 | -192.21 |
|
Cash from Financing Activities
|
-134.50 | -65.15 | 301.43 | 287.50 | -102.09 |
|
Net Cash Inflow / Outflow
|
47.90 | 92.51 | 78.81 | 46.70 | 76.98 |
Ratios
Profitability Ratios
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
ROCE (%)
|
98.11 | 22.50 | 15.53 | 25.24 | 2.31 |
|
ROE (%)
|
76.43 | 17.62 | 14.78 | 13.13 | -1.70 |
|
ROA (%)
|
49.57 | 14.50 | 9.99 | 9.94 | -1.01 |
|
EBIT Margin (%)
|
36.42 | 19.99 | 21.73 | 12.37 | 1.01 |
|
Net Margin (%)
|
27.97 | 16.21 | 15.66 | 9.78 | -4.14 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
22.67 | 24.20 | 15.50 | 35.84 | -0.11 |
|
EBIT Growth (%)
|
31.10 | 65.91 | 30.46 | 4.41 | -89.55 |
|
Net Profit Growth (%)
|
28.36 | 60.18 | 31.35 | -7.78 | -184.93 |
|
EPS Growth (%)
|
30.17 | 59.18 | 31.47 | -4.70 | -172.72 |
|
Book Value Growth (%)
|
41.18 | 19.46 | 120.22 | 84.55 | 3.63 |
Valuation Ratios
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Price / Earnings
|
28.90 | 24.14 | 99.34 | 36.49 | -16.19 |
|
Price / Book Value
|
19.04 | 4.06 | 14.17 | 4.64 | 0.28 |
|
Dividend Yield (%)
|
2.15 | 0.30 | 0.00 | 0.35 | 0.00 |
|
EV/EBITDA
|
20.86 | 16.02 | 54.42 | 20.64 | 9.43 |
|
Market Cap (₹ Cr)
|
10,410.62 | 10,075.92 | 15,882.87 | 13,848.97 | 3,411.88 |
Solvency Ratios
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.01 | 0.00 | 0.23 |
|
Short term debt to equity ratio
|
-- | 0.01 | 0.06 | -- | 0.11 |
|
Current Ratio
|
2.03 | 5.02 | 1.22 | 2.47 | 1.11 |
|
Quick Ratio
|
1.74 | 3.36 | 1.01 | 2.47 | 0.70 |
|
Interest Coverage
|
222.06 | 29.79 | 14.92 | 22.51 | 0.42 |
Operating Efficiency Ratios
| Sanofi Consumer Healthcare India | Marksans Pharma | Sai Life Sciences | Indegene | Dishman Carbogen | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
5.09 | 22.33 | 14.43 | 27.72 | 17.07 |
|
Asset Turnover
|
1.74 | 0.87 | 0.63 | 1.00 | 0.24 |
|
Receivable days
|
8.58 | 65.99 | 65.73 | 89.95 | 77.38 |
|
Inventory Days
|
20.38 | 97.24 | 22.19 | 0.00 | 120.02 |
|
Payable days
|
118.89 | 91.59 | 180.62 | -- | 172.74 |
|
Cash Conversion Cycle
|
-89.93 | 71.65 | -92.70 | -- | 24.66 |